Call Number (LC) | Title | Results |
---|---|---|
R853.C55 P83 2021 | Public engagement for improving understanding of randomized control trials. | 1 |
R853.C55 Q35 2019 | Quality assessment and quality improvement handbook for human research / | 1 |
R853.C55 R35 2018eb | Randomization, masking, and allocation concealment / | 1 |
R853.C55 R36 2012 | Randomized clinical trials of nonpharmacological treatments / | 1 |
R853.C55 R47 2022 |
Research ethics and improving the experience of clinical trial participants. Research ethics for clinical trials and precision medicine. Research ethics for clinical randomized controlled trials. |
3 |
R853.C55 R65 2002 | The role of purchasers and payers in the clinical research enterprise : workshop summary / | 1 |
R853.C55 R675 2001eb | Physician investigator handbook : GCP tools and techniques / | 1 |
R853.C55 S24 2012 | Clinical research in Asia : opportunities and challenges / | 2 |
R853.C55S36 2008 | Sample Size Tables for Clinical Studies. | 1 |
R853.C55 S36 2009 | ||
R853.C55 S36 2018 | Sample size tables for clinical, laboratory and epidemiology studies / | 1 |
R853.C55 S37 2014eb | G3P - Good Privacy Protection Practice in Clinical Research : Principles of Pseudonymization and Anonymization. | 1 |
R853.C55 S48 2021 | Setting research priorities for improving clinical trial recruitment. | 1 |
R853.C55 S56 2020 | Experiential learning of parallel, randomized, placebo-controlled trials through implementation of adjunctive phytopharmaceutical drug trial / | 1 |
R853.C55 S58 2001eb | Small clinical trials : issues and challenges / | 2 |
R853.C55 S624 2001 | Small clinical trials : issues and challenges / | 1 |
R853.C55 S64 1986 | Guide to clinical interpretation of data / | 1 |
R853.C55 .S738 2015eb | ||
R853.C55 T35 2011 |
Strategy and statistics in clinical trials : a non-statisticians guide to thinking, designing, and executing / Strategy and statistics in clinical trials a non-statisticians guide to thinking, designing, and executing / |
2 |
R853.C55 T36 2017 | Repeated measures design with generalized linear mixed models for randomized controlled trials / | 1 |